跳至主要内容
临床试验/NCT05140083
NCT05140083招募中1 期

68Ga-NOTA Evans Blue PET/CT in Patients With Lymphatic System Related Diseases

First Affiliated Hospital of Fujian Medical University1 个研究点 分布在 1 个国家目标入组 80 人开始时间: 2021年4月25日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
1 期
状态
招募中
入组人数
80
试验地点
1
主要终点
Standardized uptake value (SUV)

研究概览

简要总结

To evaluate the potential usefulness of 68Ga-NOTA Evans Blue (68Ga-NEB) positron emission tomography/computed tomography (PET/CT) for the diagnosis of primary and efficacy assessment in lymphatic system related diseases.

详细描述

Subjects with lymphatic system related diseases underwent 68Ga-NEB PET/CT either for a primary diagnosis or for efficacy assessment. Anomalies were detected by visual analysis and quantitative analysis of maximum standard uptake value (SUVmax). To compare the diagnostic sensitivity of 68Ga-NEB PET/CT lymphatic imaging with other lymphatic imaging such as 99mTc-dextran for lymphatic system related diseases.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Diagnostic
盲法
None

入排标准

年龄范围
18 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • adult population (aged between18 years and 80 years)
  • patients with suspected or new diagnosed or previously treated lymphatic system related diseases
  • patients who had scheduled 68Ga-NEB PET/CT scan
  • patients who were able to provide informed consent (signed by participant, parent or legal representative) and assent according to the guidelines of the Clinical Research Ethics Committee

排除标准

  • patients with pregnancy
  • the inability or unwillingness of the research participant, parent or legal representative to provide written informed consent.

研究组 & 干预措施

68Ga-NOTA Evans Blue PET/CT in Patients with Lymphatic System Related Diseases

Experimental

A single dose of 37-111 Mega-Becquerel (MBq) 68Ga-NOTA Evans Blue will be injected subcutaneously. PET/CT imaging will be performed at 5-30 min post- injection. Visual and quantitative method will be used to assess the PET/CT images.

干预措施: 68Ga-NOTA Evans Blue (Drug)

结局指标

主要结局

Standardized uptake value (SUV)

时间窗: through study completion, an average of 3 years

Standardized uptake value (SUV) of 68Ga-NEB for each target lesion of subject.

Visual analysis of lymphatic patency

时间窗: through study completion, an average of 3 years

The bilateral lymphatic description on 68Ga-NEB PET/CT and lymphatic SPECT imaging were compared. The patency of lymphatic vessels (including lymphatic disruption, dermal distribution, and so on, results are indicated by 0 and 1) are shown in two imagings were recorded respectively.

次要结局

  • Diagnostic efficacy(through study completion, an average of 3 years)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Weibing Miao, PhD

Director, Department of Nuclear Medicine

First Affiliated Hospital of Fujian Medical University

研究点 (1)

Loading locations...

相似试验